Surgery Partners, Inc.
Bear Case (25th pct.)
-110.2% vs price
Base Case (Median)
1.2% vs price
Bull Case (75th pct.)
131.4% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-4.53 | -131.6% | High (40%) |
| EV/EBITDA | $44.45 | 209.6% | Medium (20%) |
| EV/FCF | $29.49 | 105.4% | Medium (20%) |
| Earnings Power Value | $-0.44 | -103.1% | Medium (50%) |
Based on 4 out of 8 methods, SGRY appears fairly valued at the current price of $14.36. The base case fair value of $14.53 implies 1.2% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.